Fierce BioTech
SEPTEMBER 25, 2023
Biology Informatics Solutions Brochure From Assay Development Through Large Molecule Development. Download now to discover how to control your laboratory workflows across various assay techniques, modalities, and data types. jpiatt Mon, 09/25/2023 - 10:13 From Assay Development Through Large Molecule Development.
Broad Institute
JUNE 30, 2023
LipocyteProfiler builds on the concept of image-based profiling that was first introduced in the context of morphology mapping by Cell Painting, a high-content imaging assay developed by Broad institute scientist and Imaging Platform senior director Anne Carpenter. Online June 20, 2023. Papers cited Laber S, Strobel SM, et al.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PPD
OCTOBER 18, 2023
Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. 1 With this growth comes increased demands for laboratory services at all steps across the development process. Stay ahead of the curve with a great GMP/CMC contract laboratory partner.
Broad Institute
OCTOBER 17, 2023
Christian Soule By Rose Circeo October 17, 2023 Rees MG, Seashore-Ludlow B, Cheah JH, et al. He utilized industry-leading laboratory technology to design robust, repeatable experiments, including assay development, training, large screens, and follow-up assays. Nat Chem Biol. 2016;12(2):109-116. doi:10.1038/nchembio.1986
Drug Target Review
APRIL 7, 2025
PoLiPa technology Domainex’s Polymer Lipid Particle (PoLiPa) technology offers a versatile, detergent-free platform for the rapid, high-purity preparation of membrane proteins like GPCRs, ion channels and solute carriers, enabling assay development for these challenging targets. Jones EM, et al. doi:10.7554/elife.54895.
Alta Sciences
AUGUST 21, 2023
Choosing the Best Bioanalytical Platform for Your Program aasimakopoulos Mon, 08/21/2023 - 20:50 Choosing the right bioanalytical platform for your molecule’s intended use and program segment is crucial to obtaining reliable, robust data in a timely manner. Why Partner With Altasciences for Your Bioanalytical Projects?
FDA Law Blog: Drug Discovery
JANUARY 4, 2023
The purpose of these town halls are to discuss topics related to OTAT-regulated products, engage with product development stakeholders, and to provide information to help stakeholders to help advance drug development. The next town hall will focus on the clinical development of gene therapy products for rare diseases in February 2023.
Expert insights. Personalized for you.
52 
Let's personalize your content